Cargando…
Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes
BACKGROUND: Bypass of foregut secreted factors promoting insulin resistance is hypothesized to be one of the mechanisms by which resolution of type 2 diabetes (T2D) follows roux-en-y gastric bypass (GBP) surgery. AIM: To identify insulin resistance-associated proteins and metabolites which decrease...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011803/ https://www.ncbi.nlm.nih.gov/pubmed/24800810 http://dx.doi.org/10.1371/journal.pone.0096489 |
_version_ | 1782314847848890368 |
---|---|
author | Jüllig, Mia Yip, Shelley Xu, Aimin Smith, Greg Middleditch, Martin Booth, Michael Babor, Richard Beban, Grant Murphy, Rinki |
author_facet | Jüllig, Mia Yip, Shelley Xu, Aimin Smith, Greg Middleditch, Martin Booth, Michael Babor, Richard Beban, Grant Murphy, Rinki |
author_sort | Jüllig, Mia |
collection | PubMed |
description | BACKGROUND: Bypass of foregut secreted factors promoting insulin resistance is hypothesized to be one of the mechanisms by which resolution of type 2 diabetes (T2D) follows roux-en-y gastric bypass (GBP) surgery. AIM: To identify insulin resistance-associated proteins and metabolites which decrease more after GBP than after sleeve gastrectomy (SG) prior to diabetes remission. METHODS: Fasting plasma from 15 subjects with T2D undergoing GBP or SG was analyzed by proteomic and metabolomic methods 3 days before and 3 days after surgery. Subjects were matched for age, BMI, metformin therapy and glycemic control. Insulin resistance was calculated using homeostasis model assessment (HOMA-IR). For proteomics, samples were depleted of abundant plasma proteins, digested with trypsin and labeled with iTRAQ isobaric tags prior to liquid chromatography-tandem mass spectrometry analysis. Metabolomic analysis was performed using gas chromatography-mass spectrometry. The effect of the respective bariatric surgery on identified proteins and metabolites was evaluated using two-way analysis of variance and appropriate post-hoc tests. RESULTS: HOMA-IR improved, albeit not significantly, in both groups after surgery. Proteomic analysis yielded seven proteins which decreased significantly after GBP only, including Fetuin-A and Retinol binding protein 4, both previously linked to insulin resistance. Significant decrease in Fetuin-A and Retinol binding protein 4 after GBP was confirmed using ELISA and immunoassay. Metabolomic analysis identified significant decrease of citrate, proline, histidine and decanoic acid specifically after GBP. CONCLUSION: Greater early decrease was seen for Fetuin-A, Retinol binding protein 4, and several metabolites after GBP compared to SG, preceding significant weight loss. This may contribute to enhanced T2D remission observed following foregut bypass procedures. |
format | Online Article Text |
id | pubmed-4011803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40118032014-05-09 Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes Jüllig, Mia Yip, Shelley Xu, Aimin Smith, Greg Middleditch, Martin Booth, Michael Babor, Richard Beban, Grant Murphy, Rinki PLoS One Research Article BACKGROUND: Bypass of foregut secreted factors promoting insulin resistance is hypothesized to be one of the mechanisms by which resolution of type 2 diabetes (T2D) follows roux-en-y gastric bypass (GBP) surgery. AIM: To identify insulin resistance-associated proteins and metabolites which decrease more after GBP than after sleeve gastrectomy (SG) prior to diabetes remission. METHODS: Fasting plasma from 15 subjects with T2D undergoing GBP or SG was analyzed by proteomic and metabolomic methods 3 days before and 3 days after surgery. Subjects were matched for age, BMI, metformin therapy and glycemic control. Insulin resistance was calculated using homeostasis model assessment (HOMA-IR). For proteomics, samples were depleted of abundant plasma proteins, digested with trypsin and labeled with iTRAQ isobaric tags prior to liquid chromatography-tandem mass spectrometry analysis. Metabolomic analysis was performed using gas chromatography-mass spectrometry. The effect of the respective bariatric surgery on identified proteins and metabolites was evaluated using two-way analysis of variance and appropriate post-hoc tests. RESULTS: HOMA-IR improved, albeit not significantly, in both groups after surgery. Proteomic analysis yielded seven proteins which decreased significantly after GBP only, including Fetuin-A and Retinol binding protein 4, both previously linked to insulin resistance. Significant decrease in Fetuin-A and Retinol binding protein 4 after GBP was confirmed using ELISA and immunoassay. Metabolomic analysis identified significant decrease of citrate, proline, histidine and decanoic acid specifically after GBP. CONCLUSION: Greater early decrease was seen for Fetuin-A, Retinol binding protein 4, and several metabolites after GBP compared to SG, preceding significant weight loss. This may contribute to enhanced T2D remission observed following foregut bypass procedures. Public Library of Science 2014-05-06 /pmc/articles/PMC4011803/ /pubmed/24800810 http://dx.doi.org/10.1371/journal.pone.0096489 Text en © 2014 Jüllig et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Jüllig, Mia Yip, Shelley Xu, Aimin Smith, Greg Middleditch, Martin Booth, Michael Babor, Richard Beban, Grant Murphy, Rinki Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes |
title | Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes |
title_full | Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes |
title_fullStr | Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes |
title_full_unstemmed | Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes |
title_short | Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes |
title_sort | lower fetuin-a, retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011803/ https://www.ncbi.nlm.nih.gov/pubmed/24800810 http://dx.doi.org/10.1371/journal.pone.0096489 |
work_keys_str_mv | AT julligmia lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes AT yipshelley lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes AT xuaimin lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes AT smithgreg lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes AT middleditchmartin lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes AT boothmichael lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes AT baborrichard lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes AT bebangrant lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes AT murphyrinki lowerfetuinaretinolbindingprotein4andseveralmetabolitesaftergastricbypasscomparedtosleevegastrectomyinpatientswithtype2diabetes |